ESSA PHARMA INC's ticker is and the CUSIP is 29668H104. A total of 1 filers reported holding ESSA PHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 3.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,122,000 | 0.0% | 1,084,848 | -95.0% | 3.04% | -24.9% |
| Q1 2018 | $4,122,000 | +1005.1% | 21,696,969 | +1178.6% | 4.05% | +1400.4% |
| Q4 2017 | $373,000 | -24.2% | 1,696,969 | 0.0% | 0.27% | -2.9% |
| Q3 2017 | $492,000 | -47.3% | 1,696,969 | 0.0% | 0.28% | -52.2% |
| Q2 2017 | $933,000 | -82.4% | 1,696,969 | 0.0% | 0.58% | -83.1% |
| Q1 2017 | $5,295,000 | +42.5% | 1,696,969 | 0.0% | 3.44% | +14.2% |
| Q4 2016 | $3,716,000 | -20.4% | 1,696,969 | 0.0% | 3.02% | -15.4% |
| Q3 2016 | $4,667,000 | -6.8% | 1,696,969 | 0.0% | 3.56% | -4.1% |
| Q2 2016 | $5,006,000 | -9.2% | 1,696,969 | 0.0% | 3.71% | -2.9% |
| Q1 2016 | $5,515,000 | +19.0% | 1,696,969 | +55.6% | 3.82% | +48.3% |
| Q4 2015 | $4,636,000 | -32.7% | 1,090,909 | 0.0% | 2.58% | -33.4% |
| Q3 2015 | $6,884,000 | – | 1,090,909 | – | 3.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clarus Ventures, LLC | 2,121,212 | $6,257,000 | 5.47% |
| Omega Fund Management, LLC | 1,696,969 | $5,006,000 | 3.71% |
| AWM Investment Company, Inc. | 1,696,968 | $5,006,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 570,232 | $1,754,000 | 0.84% |
| DAFNA Capital Management LLC | 202,496 | $810,000 | 0.64% |
| Eventide Asset Management | 2,719,410 | $7,370,000 | 0.45% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,157,151 | $6,364,000 | 0.25% |
| Boxer Capital, LLC | 28,100 | $83,000 | 0.07% |
| ROYAL BANK OF CANADA | 4,200 | $12,000 | 0.00% |
| Evercore Wealth Management, LLC | 5,670 | $0 | 0.00% |